Cyclerion Therapeutics CYCN Q4 2025 Earnings Narrower Loss Surprises Analysts Rentokil Initial RTO Q4 2025 Earnings EPS Miss Weighs on Shares as Margins Face Pressure RAVE Q3 2024 Earnings Modest EPS Reported Amid Market Headwinds KGC Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds INCR Q2 2023 Earnings EPS Surges Past Estimates as Company Delivers Strong Operational Results